Medical News

RSS

Nordic Naturals introduces Omega Probiotic for optimal digestive and gastrointestinal health

Nordic Naturals, the industry leader in omega-3 fish oil, introduces Omega Probiotic, a synergistic blend of fish oil and live probiotic spores for optimal digestive and gastrointestinal health. The breakthrough formula combines two important nutrients that are commonly lacking in today's modern diet in one easy-to-take supplement that does not require refrigeration.

16 Jun 2010

Report on treatment trends in systemic lupus erythematosus

BioTrends is pleased to announce the upcoming publication of a new syndicated report, TreatmentTrends®: Systemic Lupus Erythematosus (SLE). This report will provide a comprehensive market overview of current and future treatment trends in SLE based on a primary research study fielded with 102 rheumatologists in the U.S. during the first week in June.

16 Jun 2010

Identification of key player in signaling pathway offers hope for new targeted melanoma therapies

Identification of a key player in a signaling pathway involved in the development of melanoma - the deadliest form of skin cancer - may offer hope for new targeted melanoma therapies.

16 Jun 2010

UNC researchers study why surgery happens less often in blacks with lung cancer

A new study led by UNC researchers that looks at newly diagnosed lung cancer patients and follows them from diagnosis forward is one of the first to give reasons why patients don't go to lung surgery and why surgery happens less often in blacks.

16 Jun 2010

Prevention, awareness of enlarged prostate can help save lives

We live in a country of excess where size often matters most. Supersize, grande, max, king size - but is bigger always better? Certainly not when it comes to male health and an enlarged prostate.

16 Jun 2010

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.

16 Jun 2010

Toshiba provides support to ACHE to help educate future healthcare leaders

To help educate future healthcare leaders, Toshiba America Medical Systems, Inc. is providing support to the American College of Healthcare Executives as a corporate donor for the Fund for Innovation in Healthcare Leadership. Toshiba is underwriting scholarships to ACHE's Executive Program over the next three years, enabling 60 healthcare executives to access education on leadership, innovation and management for the future.

16 Jun 2010

Physicians play stronger role in ensuring asthma patients don't waver in taking drugs: Researchers

Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks, according to researchers at Henry Ford Hospital in Detroit.

16 Jun 2010

Independent SMB recommends continuance of Allovectin-7 Phase 3 trial for metastatic melanoma

Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fourth scheduled safety analysis and recommended that the trial continue per the protocol.

16 Jun 2010

KCI's Prevena Incision Management System receives FDA clearance

Kinetic Concepts, Inc. announced today it has received 510(k) clearance from the Food and Drug Administration for the Prevena Incision Management System, a negative pressure wound therapy product designed for management of surgically closed incisions. KCI estimates more than three million procedures are performed each year worldwide that could benefit from treatment with the Prevena System, representing a potential global opportunity greater than $1 billion.

16 Jun 2010

Molecular imaging fusion with CT anatomy results in precise localization of parathyroid lesions: Research

SNM's 2010 Image of the Year illustrates the potential of hybrid molecular imaging to provide precise information about the location and function of a condition known as "hyperparathyroidism." Researchers selected this image from more than 1,500 studies presented over the course of four days during SNM's 57th Annual Meeting in Salt Lake City.

16 Jun 2010

3 new genes in genetic research of suicidal behaviour

Three genes that have barely been studied to date have now provided fresh knowledge about patients with suicidal backgrounds. This is the result of a study by a team of Spanish researchers at Mount Sinai Hospital and Columbia University in the City of New York (United States), which found that several mutations are involved. This finding could help to develop future genetic tests to identify predisposition to suicide, without ignoring the importance of social and cultural factors.

16 Jun 2010

Many Huntington's disease patients suffer from weight loss, sleeping problems

An aggregating protein causes many of the symptoms of Huntington's disease, an incurable and frequently fatal brain disorder. Mosaic winner Ahmad Aziz discovered that the abnormal protein also aggregates in the hypothalamus, the part of the brain that regulates the autonomic nervous system and the endocrine system.

16 Jun 2010

Prevalence of GID in PD patients has impact on clinical and societal outcomes: Study

New data from a retrospective cohort study showed that up to three quarters of patients with Parkinson's disease developed gastrointestinal disorders that can have a substantial adverse effect on major PD-related clinical and health economic outcomes. These data were presented at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010).

16 Jun 2010

NSF awards Florida State University $17.5M grant to build 21-tesla magnet system for large molecule analyses

The National High Magnetic Field Laboratory at Florida State University is planning to build a state-of-the-art magnet system that will transform the study of complex environmental and biological samples. A better understanding of fossil and biological fuels, for example, could lead to applications for reducing carbon emissions and the development of new, sustainable fuels.

16 Jun 2010

NTI to grant $2.8 million to promising trauma studies

The National Trauma Institute, a non-profit organization dedicated to funding trauma research in the United States, will grant $2.8 million to promising trauma studies. In its second national request for proposals, NTI seeks rigorous clinical studies, especially those addressing hemorrhage, intensive care, trauma systems or pre-hospital care.

16 Jun 2010

New online smoking-cessation study launched

Fred Hutchinson Cancer Research Center announced today that it is launching a new online study to help people quit smoking. The study, called WebQuit, is enrolling adult smokers nationwide. Participation is free to eligible individuals.

16 Jun 2010

Minapharm Pharmaceuticals acquires 95% of the share capital of ProBioGen

ProBioGen AG announced today that Minapharm Pharmaceuticals, Cairo, has completed the acquisition of 95 % of the share capital of ProBioGen, an internationally renowned German cell line development and contract manufacturing specialist. The total purchase price of EUR 30.4 million includes earn-out payments which are conditional upon the achievement of defined milestones.

16 Jun 2010

Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist

Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.

16 Jun 2010

Dutch researcher investigates causes and consequences of insomnia

The brains of older adults with chronic sleep problems look different from those of adults who have enjoyed enough sleep. Yet the older adults function well despite their lack of sleep. They switch to a continuous form of mild stress, as a result of which they sometimes even perform better than contemporaries who enjoy a good night's sleep says Dutch researcher Ellemarije Altena.

16 Jun 2010

Medical News

Nordic Naturals introduces Omega Probiotic for optimal digestive and gastrointestinal health

Report on treatment trends in systemic lupus erythematosus

Identification of key player in signaling pathway offers hope for new targeted melanoma therapies

UNC researchers study why surgery happens less often in blacks with lung cancer

Prevention, awareness of enlarged prostate can help save lives

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Toshiba provides support to ACHE to help educate future healthcare leaders

Physicians play stronger role in ensuring asthma patients don't waver in taking drugs: Researchers

Independent SMB recommends continuance of Allovectin-7 Phase 3 trial for metastatic melanoma

KCI's Prevena Incision Management System receives FDA clearance

Molecular imaging fusion with CT anatomy results in precise localization of parathyroid lesions: Research

3 new genes in genetic research of suicidal behaviour

Many Huntington's disease patients suffer from weight loss, sleeping problems

Prevalence of GID in PD patients has impact on clinical and societal outcomes: Study

NSF awards Florida State University $17.5M grant to build 21-tesla magnet system for large molecule analyses

NTI to grant $2.8 million to promising trauma studies

New online smoking-cessation study launched

Minapharm Pharmaceuticals acquires 95% of the share capital of ProBioGen

Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist

Dutch researcher investigates causes and consequences of insomnia

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News